Annual CFI
$11.54 M
+$55.94 M+126.00%
31 December 2023
Summary:
Elevation Oncology annual cash flow from investing activities is currently $11.54 million, with the most recent change of +$55.94 million (+126.00%) on 31 December 2023. During the last 3 years, it has risen by +$11.61 million (+16357.75%). ELEV annual CFI is now at all-time high.ELEV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$2.87 M
+$34.79 M+92.37%
30 September 2024
Summary:
Elevation Oncology quarterly cash flow from investing activities is currently -$2.87 million, with the most recent change of +$34.79 million (+92.37%) on 30 September 2024. Over the past year, it has increased by +$35.24 million (+92.46%). ELEV quarterly CFI is now -110.80% below its all-time high of $26.60 million, reached on 31 March 2023.ELEV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$13.27 M
+$35.24 M+72.64%
30 September 2024
Summary:
Elevation Oncology TTM cash flow from investing activities is currently -$13.27 million, with the most recent change of +$35.24 million (+72.64%) on 30 September 2024. Over the past year, it has dropped by -$29.44 million (-182.11%). ELEV TTM CFI is now -119.62% below its all-time high of $67.65 million, reached on 30 June 2023.ELEV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +126.0% | +92.5% | -182.1% |
| 3 y3 years | +10000.0% | -100.0% | -100.0% |
| 5 y5 years | - | - | - |
ELEV Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +126.0% | -110.8% | +96.4% | -119.6% | +83.3% |
| 5 y | 5 years | at high | +126.0% | -110.8% | +96.4% | -119.6% | +83.3% |
| alltime | all time | at high | +126.0% | -110.8% | +96.4% | -119.6% | +83.3% |
Elevation Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.87 M(-92.4%) | -$13.27 M(-72.6%) |
| June 2024 | - | -$37.66 M(-281.9%) | -$48.52 M(-959.8%) |
| Mar 2024 | - | $20.70 M(+215.5%) | $5.64 M(-51.1%) |
| Dec 2023 | $11.54 M(-126.0%) | $6.56 M(-117.2%) | $11.54 M(-28.6%) |
| Sept 2023 | - | -$38.12 M(-331.0%) | $16.16 M(-76.1%) |
| June 2023 | - | $16.50 M(-38.0%) | $67.65 M(+10.0%) |
| Mar 2023 | - | $26.60 M(+137.9%) | $61.47 M(-238.5%) |
| Dec 2022 | -$44.40 M | $11.18 M(-16.3%) | -$44.40 M(-20.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $13.37 M(+29.4%) | -$55.58 M(-19.4%) |
| June 2022 | - | $10.33 M(-113.0%) | -$68.94 M(-13.0%) |
| Mar 2022 | - | -$79.27 M(<-9900.0%) | -$79.27 M(<-9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
| Dec 2020 | -$71.00 K | - | - |
FAQ
- What is Elevation Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Elevation Oncology?
- What is Elevation Oncology annual CFI year-on-year change?
- What is Elevation Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Elevation Oncology?
- What is Elevation Oncology quarterly CFI year-on-year change?
- What is Elevation Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Elevation Oncology?
- What is Elevation Oncology TTM CFI year-on-year change?
What is Elevation Oncology annual cash flow from investing activities?
The current annual CFI of ELEV is $11.54 M
What is the all time high annual CFI for Elevation Oncology?
Elevation Oncology all-time high annual cash flow from investing activities is $11.54 M
What is Elevation Oncology annual CFI year-on-year change?
Over the past year, ELEV annual cash flow from investing activities has changed by +$55.94 M (+126.00%)
What is Elevation Oncology quarterly cash flow from investing activities?
The current quarterly CFI of ELEV is -$2.87 M
What is the all time high quarterly CFI for Elevation Oncology?
Elevation Oncology all-time high quarterly cash flow from investing activities is $26.60 M
What is Elevation Oncology quarterly CFI year-on-year change?
Over the past year, ELEV quarterly cash flow from investing activities has changed by +$35.24 M (+92.46%)
What is Elevation Oncology TTM cash flow from investing activities?
The current TTM CFI of ELEV is -$13.27 M
What is the all time high TTM CFI for Elevation Oncology?
Elevation Oncology all-time high TTM cash flow from investing activities is $67.65 M
What is Elevation Oncology TTM CFI year-on-year change?
Over the past year, ELEV TTM cash flow from investing activities has changed by -$29.44 M (-182.11%)